Literature DB >> 15626531

Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials.

Maria Donald1, Jo Dower, David Kavanagh.   

Abstract

The purpose of this paper is to conduct a qualitative review of randomised controlled trials in relation to the treatment of adults with co-occurring mental health and substance use disorder (MH/SUD). In particular, integrated approaches are compared with non-integrated approaches to treatment. Ten articles were identified for inclusion in the review. The findings are equivocal with regard to the superior efficacy of integrated approaches to treatment, although the many limitations of the studies need to be considered in our understanding of this finding. Clearly, this is an extremely challenging client group to engage and maintain in intervention research, and the complexity and variability of the problems render control particularly difficult. The lack of available evidence to support the superiority of integration is discussed in relation to these challenges. Much remains to be investigated with regard to integrated management and care for people with co-occurring and MH/SUD, particularly for specific combinations of dual diagnosis and giving consideration to the level of inter-relatedness between the disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15626531     DOI: 10.1016/j.socscimed.2004.06.052

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  35 in total

1.  Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders.

Authors:  Ramin Mojtabai; Lian-Yu Chen; Christopher N Kaufmann; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2013-08-29

Review 2.  Co-occurring disorders in substance abuse treatment: issues and prospects.

Authors:  Patrick M Flynn; Barry S Brown
Journal:  J Subst Abuse Treat       Date:  2007-06-15

3.  Psychosocial treatment programs for people with both severe mental illness and substance misuse.

Authors:  M Cleary; G E Hunt; S Matheson; N Siegfried; G Walter
Journal:  Schizophr Bull       Date:  2008-01-29       Impact factor: 9.306

4.  Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.

Authors:  Astrid Brousselle; Lise Lamothe; Céline Mercier; Michel Perreault
Journal:  Eval Program Plann       Date:  2006-12-26

5.  Enhancing health-care workers' understanding and thinking about people living with co-occurring mental health and substance use issues through consumer-led training.

Authors:  Véronique Roussy; Nikos Thomacos; Annette Rudd; Belinda Crockett
Journal:  Health Expect       Date:  2013-10-10       Impact factor: 3.377

6.  Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders.

Authors:  Daniel William Chandler; Gary Spicer
Journal:  Community Ment Health J       Date:  2006-08-24

7.  Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jean Caron
Journal:  Psychiatr Q       Date:  2015-09

8.  A meta-analysis of the effect of substance use interventions on emotion outcomes.

Authors:  Dahyeon Kang; Catharine E Fairbairn; Talia A Ariss
Journal:  J Consult Clin Psychol       Date:  2019-12

9.  Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial.

Authors:  Michael Kidorf; Robert K Brooner; Neeraj Gandotra; Denis Antoine; Van L King; Jessica Peirce; Sharon Ghazarian
Journal:  Drug Alcohol Depend       Date:  2013-07-15       Impact factor: 4.492

10.  Chronic care management for substance dependence in primary care among patients with co-occurring disorders.

Authors:  Tae Woo Park; Debbie M Cheng; Jeffrey H Samet; Michael R Winter; Richard Saitz
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.